Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 65

Sort by

Sort Order Select

Journal Articles

Combined Inhibition of MCL1 By AZD5991 and BCL2/Bclxl By AZD4320 As Promising Strategies to Overcome Acute Leukemia Tumor Burden and Niche Chemoresistance

Maura Lima Pereira Bueno, Leonardo Artico, Adriana Silva Santos Duarte, Audrey Basso, Jose Andres Yunes, Sara T. Olalla Saad, Fernanda Marconi Roversi

Blood (2022) 140 (Supplement 1): 4943–4944.

https://doi.org/10.1182/blood-2022-158620

Published: 2022

Journal Articles

Cognitive Assessment in Brazilian Adults with Sickle Cell Disease (SCD): The Burdens of Sociocultural Background and Correlations with Neuroimaging Findings

Pedro Junqueira Fleury Silva, Caroline Martins Silva, Brunno Machado de Campos, Paula De Melo Campos, Samuel de Souza Medina, Andreza Lamonica, Fernando Cendes, Fernando Ferreira Costa, Sara T Olalla Saad, Bruno Deltreggia Benites

Blood (2022) 140 (Supplement 1): 2576–2577.

https://doi.org/10.1182/blood-2022-166596

Published: 2022

Journal Articles

Individual Red Blood Cell Fetal Hemoglobin Concentrations Determined By Imaging Flow Cytometry and the Number of F Cells Are Very Good Predictors of Clinical Response to Increased Level of HbF and Are Associated with Hemolysis, Tricuspid Regurgitant Jet Velocity, and Sickle Retinopathy in Adult Sickle Cell Disease Patients

Daniela Pinheiro Leonardo, Myriam Salazar-Terreros, Stephan Menzel, Carolina Lanaro, Dulcinéia Martins de Albuquerque, Sara T Olalla Saad, Kleber Yotsumoto Fertrin, Fernando Ferreira Costa

Blood (2022) 140 (Supplement 1): 2510–2511.

https://doi.org/10.1182/blood-2022-169182

Published: 2022

Journal Articles

HCK Inhibition Displays Antineoplastic Activity on Acute Leukemia and Promotes Immune Regulation of the Bone Marrow Tumor Microenvironment

Fernanda Marconi Roversi, Maura Lima Pereira Bueno, Audrey Basso, Adriana Silva Santos Duarte, Juliete A.F. Silva, Sara T Olalla Saad

Blood (2022) 140 (Supplement 1): 7806–7807.

https://doi.org/10.1182/blood-2022-158579

Published: 2022

Journal Articles

Myelodysplastic Syndromes: Have You Seen Your Patient Beyond His Hemoglobin?

Raíssa Pires Camargo Ebert, Mariana Munari Magnus, Cristina Bueno Terzi, Antonio Luis Eiras Falcão, Fernando Ferreira Costa, Sara T Olalla Saad, Paula De Melo Campos

Blood (2021) 138 (Supplement 1): 4660.

https://doi.org/10.1182/blood-2021-153569

Published: 2021

Journal Articles

Crizanlizumab Therapy Is Associated with Lower Levels of Circulating Extracellular Vesicles in Sickle Cell Disease Patients

Cristiane Maria de Souza, Carolina Lanaro, Irene Pereira dos Santos, Oladele Olatunya, Sara T Olalla Saad, Bruno Deltreggia Benites, Paula De Melo Campos, Kleber Yotsumoto Fertrin, Fernando Ferreira Costa

Blood (2021) 138 (Supplement 1): 955.

https://doi.org/10.1182/blood-2021-153377

Published: 2021

Journal Articles

Final Results of the Fibromet Trial: An Open Label Phase II Study to Evaluate Metformin Effects on Bone Marrow Fibrosis and Disease Progression in Primary Myelofibrosis Patients

Paula De Melo Campos, Katia B Pagnano, Rubia Isler Mancuso, Fernanda Isabel Della Via, Ângela Condotta Tinoco, Guilherme Rossi Assis-Mendonça, Leandro Luiz Lopes Freitas, Fabiola Traina, Sara T Olalla Saad

Blood (2021) 138 (Supplement 1): 2584.

https://doi.org/10.1182/blood-2021-151077

Published: 2021

Journal Articles

A Novel WNT5A-Mimicking Peptide Affects Leukemia Cell Survival in the Bone Marrow Microenvironment

Fernanda Marconi Roversi, Maura Lima Pereira Bueno, Rafael Gonçalves Barbosa Gomes, Guilherme Rossi Assis-Mendonça, Paulo Latuf Filho, Adriana Silva Santos Duarte, Sara T Olalla Saad

Blood (2021) 138 (Supplement 1): 2949.

https://doi.org/10.1182/blood-2021-148744

Published: 2021

Journal Articles

Platelet Counts and Mean Platelet Volume As Markers of Clinical Severity in Sickle Cell Disease

Caroline Martins Silva, Samuel Souza Medina, MD MSc, Paula De Melo Campos, MD PhD, Fernando Ferreira Costa, MD PhD, Sara T Olalla Saad, MD PhD, Bruno Deltreggia Benites, MD PhD

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-138486

Published: 2020

Journal Articles

Reduction of ARHGAP21 Alters Platelet Biogenesis in Vitro and Accelerates Hemostatic Response In Vivo

Mariana Lazarini, PhD, Vanessa Bernusso, MSc, Karla P.V Ferro, PhD, Adriana Silva Santos Duarte, PhD, Cristina Pontes Vicente, PhD, Erich V De Paula, MD PhD, Sara T Olalla Saad, MD PhD

Blood (2020) 136 (Supplement 1): 13.

https://doi.org/10.1182/blood-2020-141109

Published: 2020

Journal Articles

Analysis of the Eligibility of Patients with Sickle Cell Disease for Palliative Care

Pedro de Oliveira Toro da Silva, Cristina Bueno Terzi, MD PhD, Antonio Luis Eiras Falcão, MD PhD, Sara T Olalla Saad, PhD, Fernando Ferreira Costa, MD PhD, Paula De Melo Campos, MD

Blood (2019) 134 (Supplement_1): 4681.

https://doi.org/10.1182/blood-2019-128884

Published: 2019

Journal Articles

Sickle Cell Disease Patients Have Altered Number and Function of Dendritic Cells

Renata Sesti-Costa, PhD, Carolina Lanaro, BSc, PhD, Dulcinéia Martins de Albuquerque, BSc, PhD, Sara T Olalla Saad, PhD, Fernando Ferreira Costa, MD PhD

Blood (2019) 134 (Supplement_1): 3569.

https://doi.org/10.1182/blood-2019-129854

Published: 2019

Journal Articles

Analysis of Metformin Effects on Bone Marrow Fibrosis and Disease Progression in Primary Myelofibrosis Patients: Preliminary Results of an Open Label Phase II Trial (FIBROMET)

Paula De Melo Campos, MD, Katia B Pagnano, MD PhD, Rubia Mancuso, Francisco Breno S. Teófilo, Juan L Coelho-Silva, BSc, MSc, Fernanda I Della Via, MSc, Leandro Luiz Lopes Freitas, MD PhD, Hernandes F. Carvalho, PhD, Fernando Ferreira Costa, MD PhD, Fabiola Traina, MD PhD, Sara T Olalla Saad, PhD

Blood (2019) 134 (Supplement_1): 554.

https://doi.org/10.1182/blood-2019-130648

Published: 2019

Journal Articles

Quiescence/Mobilization of Hematopoietic Immature Cells Induced By Polyphenols through Modulation of APC/EPCR/PAR-1 Axis

Cristiane Okuda Torello, PhD, Erich V De Paula, MD PhD, Rodrigo Naoto Shiraishi, PhDstudent, Santos Irene, PhD, Fernanda I Della Via, MSc, Mariana Pissarra, training/fellow, Marisa Claudia Alvarez De Prax, PhD, Mary L. S. Queiroz, MD PhD, Sara T Olalla Saad, PhD

Blood (2019) 134 (Supplement_1): 4996.

https://doi.org/10.1182/blood-2019-127354

Published: 2019

Journal Articles

Mutations in Triple-Negative Patients with Myeloproliferative Neoplasms

Maria Carolina Costa Melo Svidnicki, PhD, Paula De Melo Campos, MD, Moisés Alves Ferreira Filho, PhD, Caio Augusto Leme Fujiura, Tetsuichi Yoshizato, MD PhD, Hideki Makishima, MD PhD, Seishi Ogawa, MD PhD, Sara T Olalla Saad, PhD

Blood (2019) 134 (Supplement_1): 5395.

https://doi.org/10.1182/blood-2019-128764

Published: 2019

Journal Articles

Epigallocatechin-3-Gallate Induces Cellular Differentiation and Reduces Leukemia Burden in PML/Rarα Mice By Increasing Reactive Oxygen Species and Reducing PIN1 Expression

Fernanda I Della Via, MSc, Rodrigo Naoto Shiraishi, PhDstudent, Santos Irene, PhD, Karla P Ferro, PhD, Myriam Salazar-Terreros, PhDMSc, Gilberto C Franchi Junior, Eduardo M Rego, MD PhD, Sara T Olalla Saad, PhD, Cristiane Okuda Torello, PhD

Blood (2019) 134 (Supplement_1): 5765.

https://doi.org/10.1182/blood-2019-130542

Published: 2019

Journal Articles

NRF2 Is Targeted By the Polyphenol Quercetin and Induces Apoptosis, in Part, through up Regulation of Pro Apoptotic Mirs

Marisa Claudia Alvarez De Prax, PhD, Karla P.V Ferro, PhD, Irene Santos, Cristiane Okuda Torello, PhD, Myriam Salazar-Terreros, PhDMSc, Sara T Olalla Saad, PhD

Blood (2019) 134 (Supplement_1): 2529.

https://doi.org/10.1182/blood-2019-130982

Published: 2019

Journal Articles

Expression of Notch Pathway Components in Primary Samples of Allogeneic Hematopoietic Cell Transplant Patients with Chronic Graft Versus Host Disease

Marcos Paulo Colella, MD, Fernanda Soares Niemann, MSc, Beatriz Corey Morini, Matheus Lopes, PhD, Francisco José Penteado Aranha, MD PhD, Afonso Celso Vigorito, MD PhD, Sara T Olalla Saad, PhD, Patricia Favaro, PhD

Blood (2019) 134 (Supplement_1): 5600.

https://doi.org/10.1182/blood-2019-128785

Published: 2019

Journal Articles

A Novel Chemical Compound Inhibiting Hematopoietic Cell Kinase (iHCK) Has a Synergic Effect with Azacytidine (Aza) or Cytarabine (Ara-C) for Acute Myeloid Leukemia Treatment

Fernanda Marconi Roversi, Maura Lima Pereira Bueno, undergraduate, Cristiane Okuda Torello, PhD, Fernanda I Della Via, MSc, Renata Giardini Rosa, PhD, Juares Ednaldo Romero Bianco, PhD, Adriana Silva Santos Duarte, PhD, Eduardo M Rego, MD PhD, Alessio Molinari, Maurizio Botta, Sara T Olalla Saad, PhD

Blood (2019) 134 (Supplement_1): 4650.

https://doi.org/10.1182/blood-2019-128959

Published: 2019

Journal Articles

Polyphenols Modulate Quiescence/Mobilization of Hematopoietic Immature Cells through APC/EPCR/PAR-1 Axis

Cristiane O Torello, PhD, Erich Vinicius De Paula, MD PhD, Rodrigo Naoto Shiraishi, training/fellow, Tamara C. Lopes de Castro, undergraduate, Fernanda Martins, PhD, Fernanda I Della Via, PhDstudent, Marisa Claudia Alvarez De Prax, PhD, Mary L. S. Queiroz, MD PhD, Sara T. Olalla Saad, MD PhD

Blood (2018) 132 (Supplement 1): 3830.

https://doi.org/10.1182/blood-2018-99-114902

Published: 2018

NARROW

Combined Inhibition of MCL1 By AZD5991 and BCL2/Bclxl By AZD4320 As Promising Strategies to Overcome Acute Leukemia Tumor Burden and Niche Chemoresistance

Cognitive Assessment in Brazilian Adults with Sickle Cell Disease (SCD): The Burdens of Sociocultural Background and Correlations with Neuroimaging Findings

HCK Inhibition Displays Antineoplastic Activity on Acute Leukemia and Promotes Immune Regulation of the Bone Marrow Tumor Microenvironment

Myelodysplastic Syndromes: Have You Seen Your Patient Beyond His Hemoglobin?

Crizanlizumab Therapy Is Associated with Lower Levels of Circulating Extracellular Vesicles in Sickle Cell Disease Patients

Final Results of the Fibromet Trial: An Open Label Phase II Study to Evaluate Metformin Effects on Bone Marrow Fibrosis and Disease Progression in Primary Myelofibrosis Patients

A Novel WNT5A-Mimicking Peptide Affects Leukemia Cell Survival in the Bone Marrow Microenvironment

Platelet Counts and Mean Platelet Volume As Markers of Clinical Severity in Sickle Cell Disease

Reduction of ARHGAP21 Alters Platelet Biogenesis in Vitro and Accelerates Hemostatic Response In Vivo

Analysis of the Eligibility of Patients with Sickle Cell Disease for Palliative Care

Sickle Cell Disease Patients Have Altered Number and Function of Dendritic Cells

Analysis of Metformin Effects on Bone Marrow Fibrosis and Disease Progression in Primary Myelofibrosis Patients: Preliminary Results of an Open Label Phase II Trial (FIBROMET)

Quiescence/Mobilization of Hematopoietic Immature Cells Induced By Polyphenols through Modulation of APC/EPCR/PAR-1 Axis

Mutations in Triple-Negative Patients with Myeloproliferative Neoplasms

Epigallocatechin-3-Gallate Induces Cellular Differentiation and Reduces Leukemia Burden in PML/Rarα Mice By Increasing Reactive Oxygen Species and Reducing PIN1 Expression

NRF2 Is Targeted By the Polyphenol Quercetin and Induces Apoptosis, in Part, through up Regulation of Pro Apoptotic Mirs

Expression of Notch Pathway Components in Primary Samples of Allogeneic Hematopoietic Cell Transplant Patients with Chronic Graft Versus Host Disease

A Novel Chemical Compound Inhibiting Hematopoietic Cell Kinase (iHCK) Has a Synergic Effect with Azacytidine (Aza) or Cytarabine (Ara-C) for Acute Myeloid Leukemia Treatment

Polyphenols Modulate Quiescence/Mobilization of Hematopoietic Immature Cells through APC/EPCR/PAR-1 Axis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only